Leguelinel-Blache Géraldine, Dubois Florent, Bouvet Sophie, Roux-Marson Clarisse, Arnaud Fabrice, Castelli Christel, Ray Valérie, Kinowski Jean-Marie, Sotto Albert
From the Department of Pharmacy, Nîmes University Hospital, Nîmes, France (GLB, FD, CRM, FA, JMK); Laboratory of Biostatistics, Epidemiology, Clinical Research and Health Economics, EA2415, University Institute of Clinical Research, Montpellier University, Montpellier, France (GLB, CRM, CC, JMK); Department of Biostatistics, Epidemiology, Clinical Research and Health Economics, Nîmes University Hospital, Nîmes, France (SB, CC); Department of General Medicine, Nîmes University Hospital, Nîmes, France (VR); and Department of Infectious and Tropical Diseases, Nîmes University Hospital, Nîmes, France (AS).
Medicine (Baltimore). 2015 Oct;94(41):e1805. doi: 10.1097/MD.0000000000001805.
Quality of transitions of care is one of the first concerns in patient safety. Redesigning the discharge process to incorporate clinical pharmacy activities could reduce the incidence of postdischarge adverse events by improving medication adherence. The present study investigated the value of pharmacist counseling sessions on primary medication adherence after hospital discharge.This study was conducted in a 1844-bed hospital in France. It was divided in an observational period and an interventional period of 3 months each. In both periods, ward-based clinical pharmacists performed medication reconciliation and inpatient follow-up. In interventional period, initial counseling and discharge counseling sessions were added to pharmaceutical care. The primary medication adherence was assessed by calling community pharmacists 7 days after patient discharge.We compared the measure of adherence between the patients from the observational period (n = 201) and the interventional period (n = 193). The rate of patients who were adherent increased from 51.0% to 66.7% between both periods (P < 0.01). When discharge counseling was performed (n = 78), this rate rose to 79.7% (P < 0.001). The multivariate regression performed on data from both periods showed that age of at least 78 years old, and 3 or less new medications on discharge order were predictive factors of adherence. New medications ordered at discharge represented 42.0% (n = 1018/2426) of all medications on discharge order. The rate of unfilled new medications decreased from 50.2% in the observational period to 32.5% in the interventional period (P < 10). However, patients included in the observational period were not significantly more often readmitted or visited the emergency department than the patients who experienced discharge counseling during the interventional period (45.3% vs. 46.2%; P = 0.89).This study highlights that discharge counseling sessions are essential to improve outpatients' primary medication adherence. We identified predictive factors of primary nonadherence in order to target the most eligible patients for discharge counseling sessions. Moreover, implementation of discharge counseling could be facilitated by using Health Information Technology to adapt human resources and select patients at risk of nonadherence.
医疗护理转接质量是患者安全方面首要关注的问题之一。重新设计出院流程以纳入临床药学活动,可通过提高用药依从性来降低出院后不良事件的发生率。本研究调查了药师咨询服务对出院后主要用药依从性的价值。
本研究在法国一家拥有1844张床位的医院开展。研究分为观察期和干预期,各为期3个月。在两个时期,病房临床药师均进行用药核对和住院患者随访。在干预期,初始咨询和出院咨询服务被纳入药学服务。主要用药依从性通过在患者出院7天后致电社区药师进行评估。
我们比较了观察期患者(n = 201)和干预期患者(n = 193)的依从性指标。两个时期之间,依从患者的比例从51.0%增至66.7%(P < 0.01)。当进行出院咨询时(n = 78),这一比例升至79.7%(P < 0.001)。对两个时期的数据进行多变量回归分析显示,年龄至少78岁以及出院医嘱中有3种或更少新用药是依从性的预测因素。出院时开具的新用药占出院医嘱中所有用药的42.0%(n = 1018/2426)。未配取新用药的比例从观察期的50.2%降至干预期的32.5%(P < 0.01)。然而,观察期纳入的患者再次入院或前往急诊科就诊的频率与干预期接受出院咨询的患者相比,并无显著差异(45.3%对46.2%;P = 0.89)。
本研究强调,出院咨询服务对于提高门诊患者的主要用药依从性至关重要。我们确定了主要不依从的预测因素,以便确定最适合接受出院咨询服务的患者。此外,利用健康信息技术来调整人力资源并筛选有不依从风险的患者,可促进出院咨询服务的实施。